New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
190.74+1.15 (+0.61%)
At close: 04:00PM EDT
190.74 0.00 (0.00%)
After hours: 06:18PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
431,790
474,624
486,226
390,982
364,304
-
Depreciation & amortisation
330,823
314,124
303,870
265,540
234,924
-
Deferred income taxes
-47,421
-50,903
-35,884
-24,006
-133
-
Stock-based compensation
75,643
72,048
73,617
71,474
56,341
-
Change in working capital
-18,727
-102,380
-152,554
42,942
-26,275
-
Accounts receivable
-
-
-
-
-85,627
-8,323
Inventory
-19,880
-62,301
-78,523
-25,159
-18,379
-
Accounts payable
-1,878
-20,427
-2,652
44,901
748
-
Other working capital
486,916
365,370
294,907
532,027
380,015
-
Other non-cash items
9,263
3,402
17,973
-31,736
13,612
-
Net cash provided by operating activities
749,816
683,898
619,640
760,799
546,575
-
Cash flows from investing activities
Investments in property, plant and equipment
-262,900
-318,528
-324,733
-228,772
-166,560
-
Acquisitions, net
-150,098
-194,785
-283,392
-1,293,095
-418,628
-
Purchases of investments
-67,064
-54,215
-158,274
-45,555
-26,692
-
Sales/maturities of investments
16,083
6,667
4,549
6,532
11,401
-
Other investing activities
-1,607
-2,294
-9,347
264
-1,065
-
Net cash used for investing activities
-465,586
-563,155
-607,922
-1,437,932
-601,544
-
Cash flows from financing activities
Debt repayment
-1,521,971
-851,676
-2,932,636
-6,281,132
-2,200,400
-
Common stock repurchased
-18,442
-24,155
-38,651
-40,707
-23,979
-
Other financing activities
-34,363
-11,640
-48,650
-2,328
-5,947
-
Net cash used provided by (used for) financing activities
-306,810
-85,521
-42,397
672,598
47,248
-
Net change in cash
-27,773
43,266
-5,100
13,195
-6,927
-
Cash at beginning of period
208,777
241,214
246,314
233,119
240,046
-
Cash at end of period
186,197
284,480
241,214
246,314
233,119
-
Free cash flow
Operating cash flow
749,816
683,898
619,640
760,799
546,575
-
Capital expenditure
-262,900
-318,528
-324,733
-228,772
-166,560
-
Free cash flow
486,916
365,370
294,907
532,027
380,015
-